Recommendation for use of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate, and hepatitis B vaccine in infants

In April 2020, the Ministry of Food and Drug Safety licensed a hexavalent combined diphtheria and tetanus toxoids and acellular pertussis (DTaP), inactivated poliovirus (IPV), Haemophilus influenzae type b (Hib) conjugated to tetanus protein, and hepatitis B (HepB) (recombinant DNA) vaccine, DTa-PIP...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Hye-Kyung, Park, Su Eun, Kim, Yae-Jean, Jo, Dae Sun, Kim, Yun-Kyung, Eun, Byung-Wook, Lee, Taek-Jin, Lee, Jina, Lee, Hyunju, Kim, Ki Hwan, Cho, Eun Young, Ahn, Jong Gyun, Choi, Eun Hwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Pediatric Society 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650817/
https://www.ncbi.nlm.nih.gov/pubmed/34098627
http://dx.doi.org/10.3345/cep.2021.00507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650817/
https://www.ncbi.nlm.nih.gov/pubmed/34098627
http://dx.doi.org/10.3345/cep.2021.00507

Ejemplares similares